Carregant...
Summary of Clinical Experiences With Tamsulosin for the Treatment of Benign Prostatic Hyperplasia
Tamsulosin, a uroselective α(1A)-adrenergic-receptor antagonist, has been shown to improve lower urinary tract symptoms associated with benign prostatic hyperplasia. It has a better side effect profile than earlier α-adrenergic-receptor antagonists, which were initially developed as antihypertensive...
Guardat en:
| Autor principal: | |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
MedReviews, LLC
2005
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC1477611/ https://ncbi.nlm.nih.gov/pubmed/16986050 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|